There were no differences in CD19 mRNA, CD19 protein, or PAX5 mRNA levels in pre-CART19 pro-B-like B-ALL cells (Supplementary Fig. 3F), consistent with our findings at the protein level (Fig. 1E). Here, PAX5 is linked to acute lymphoblastic leukemia.